We then extended the analysis to genes belonging to the group of iron-binding proteins, which are known to protect the lysosomal compartment against drug-induced LMP [21,32,33] and already reported to be dysregulated in some breast cancer subtypes [34,35,36]. Here, PDLIM7 is linked to breast carcinoma.